Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)EBIATLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsWages, Salaries and Other
Ratios

Surgery Partners (SGRY) Accumulated Depreciation & Amortization: 2014-2025

Historic Accumulated Depreciation & Amortization for Surgery Partners (SGRY) over the last 12 years, with Q3 2025 value amounting to $39.5 million.

  • Surgery Partners' Accumulated Depreciation & Amortization fell 2131.47% to $39.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $39.5 million, marking a year-over-year decrease of 2131.47%. This contributed to the annual value of $152.6 million for FY2024, which is 2921.25% up from last year.
  • According to the latest figures from Q3 2025, Surgery Partners' Accumulated Depreciation & Amortization is $39.5 million, which was down 2131.47% from $40.3 million recorded in Q2 2025.
  • Surgery Partners' 5-year Accumulated Depreciation & Amortization high stood at $454.4 million for Q4 2023, and its period low was $25.2 million during Q2 2021.
  • For the 5-year period, Surgery Partners' Accumulated Depreciation & Amortization averaged around $118.4 million, with its median value being $37.9 million (2025).
  • Its Accumulated Depreciation & Amortization has fluctuated over the past 5 years, first soared by 4384.57% in 2021, then crashed by 9253.96% in 2024.
  • Quarter analysis of 5 years shows Surgery Partners' Accumulated Depreciation & Amortization stood at $272.3 million in 2021, then skyrocketed by 37.46% to $374.3 million in 2022, then increased by 21.4% to $454.4 million in 2023, then tumbled by 92.54% to $33.9 million in 2024, then grew by 16.52% to $39.5 million in 2025.
  • Its last three reported values are $39.5 million in Q3 2025, $40.3 million for Q2 2025, and $36.3 million during Q1 2025.